Joint Prague-Weizmann Winter School on Drug Discovery Program
Print Full program
Monday, December 3
| Time |
Session/Lecture info |
| 13:30-20:00 |
Monday, December 3
|
| 13:30-15:00 |
Registration & coffee
|
| 15:00-16:00 |
Opening remarks and address by the Czech ambassador to Israel
His Excellency Mr. Martin Stropnický
|
| 16:00-16:45 |
Petr Vachal , MSD, US
Drug Discovery Enabled
|
| 16:45-17:30 |
Yosef Yarden , Weizmann, IL
Treatment of lung cancer using combinations of antibodies and kinase inhibitors
|
| 17:30-20:00 |
Opening reception
|
Tuesday, December 4
| Time |
Session/Lecture info |
| 08:00-22:00 |
Tuesday, December 4
|
| 08:00-09:00 |
Registration & coffee
|
| 09:00-09:45 |
Masha Niv, HUJI, IL
The relation between bitterness, toxicity and therapeutic potential
|
| 09:45-10:30 |
Dan Svozil, UCT, CZ
Introduction to Computational Drug Design
|
| 10:30-11:00 |
Coffee Break
|
| 11:00-11:45 |
John Overington , Medicines Discovery Catapult, UK
Data for Drug Discovery
|
| 11:45-13:00 |
Lunch
|
| 13:00-22:00 |
Tour to Jerusalem
|
Wednesday, December 5
| Time |
Session/Lecture info |
| 08:00-18:00 |
Wednesday, December 5
|
| 08:00-09:00 |
Registration & coffee
|
| 09:00-09:45 |
Iris Alroy, Anima Biopharm, IL
Discovery of Protein Translation Modulators as Therapeutic Drugs
|
| 09:45-10:30 |
Miguel Weil , TAU, IL
Image based high content analysis as a platform for drug
|
| 10:30-11:00 |
Coffee Break
|
| 11:00-11:45 |
Jan Konvalinka , IOCB, CZ
Novel chemical biology tools for protein imaging and drug discovery
|
| 11:45-12:30 |
Lenka Maletinska, IOCB, CZ
Obesity, diabetes and Alzheimer's disease crosstalk: new therapeutic potential of anorexigenic neuropeptides
|
| 12:30-14:00 |
Lunch
|
| 14:00-14:45 |
Avigdor Schertz, Weizmann, IL
Vascular targeted photo-dynamic therapy with Tookad; The road to approved paradigm shift in cancer management
|
| 14:45-15:30 |
Zdenek Hostomsky , IOCB, CZ
Inhibiting PARP - from idea to registration
|
| 15:30-18:00 |
Poster Session
|
Thursday, December 6
| Time |
Session/Lecture info |
| 08:00-18:30 |
Thursday, December 6
|
| 08:00-09:00 |
Registration & coffee
|
| 09:00-09:45 |
Annika Jenmalm Jensen , Karolinska Institute, SE
Chemical Biology in Drug Discovery
|
| 09:45-10:30 |
Paul Brennan, Oxford, UK
Chemical Probes in Target Discovery
|
| 10:30-10:45 |
Haim Barr, Weizmann, IL
The EU Open screen A European Chemical Biology Toolbox
|
| 10:45-11:15 |
Coffee Break
|
| 11:15-12:00 |
Vaclav Veverka, IOCB, CZ
Biomolecular NMR in knowledge-based drug design
|
| 12:00-12:45 |
Frank von Delft, Oxford, UK
XChem fragment screening and streamlined follow-up
|
| 12:45-14:15 |
Lunch
|
| 14:15-15:45 |
Tour of the Weizmann Campus
|
| 15:45-16:30 |
Nir London, Weizmann, IL
Covalent Drug Discovery
|
| 16:30-17:15 |
Alessio Ciulli , U. Dundee, UK
How PROTACs work
|
| 17:15-17:45 |
Coffee Break
|
| 17:45-18:30 |
Irit Sagi, Weizmann, IL
The evolution of Matrix Protease inhibitors
|
Friday, December 7
| Time |
Session/Lecture info |
| 08:00-14:00 |
Friday, December 7th
|
| 08:00-09:00 |
Registration & coffee
|
| 09:00-09:45 |
Stephan Bachmann, Roche, CH
Catalysis as Key Technology for the Synthesis and Scale-up of APIs and Their Intermediates
|
| 09:45-10:30 |
Radim Nencka , IOCB, CZ
Design of novel enzyme inhibitors – PI4KB and nSMase2
|
| 10:30-11:00 |
Coffee Break
|
| 11:00-11:45 |
Chakrapani Subramanyam, Weizmann, IL / Pfizer, US
Role of Medchem in Drug discovery Collection of Vignette?s from Personal experience
|
| 11:45-12:30 |
David Andrews, Astra Zeneca, UK
The discovery of AZD4547
|
| 12:30-13:30 |
Lunch
|
| 13:30-14:00 |
Closing and farewell
|
Nir London, WIS
Haim Barr, WIS
Martin Fusek, IOCB, Prague
Radek Cibulka, UCT, Prague
Sponsors
Coordinator & Accessibility Issues
Talia Suissa
talias@weizmann.ac.il
